Thyreoidea<strong>cancer</strong> – <strong>udkast</strong> <strong>Kliniske</strong> <strong>retningslinier</strong> – revision – juni <strong>2009</strong> <strong>cancer</strong>. J Surg.Oncol 2007;96:173-5. 186. Travagli JP, Cailleux AF, Ricard M, Baudin E, Caillou B, Parmentier C et al. Combination of radioiodine (131I) and probe-guided surgery <strong>for</strong> persistent or recurrent thyroid carcinoma. J Clin Endocrinol.Metab 1998;83:2675-80. 187. Rubello D, Salvatori M, Ardito G, Mariani G, Al Nahhas A, Gross MD et al. Iodine-131 radio-guided surgery in differentiated thyroid <strong>cancer</strong>: outcome on 31 patients and review of the literature. Biomed.Pharmacother. 2007;61:477-81. 188. Negele T, Meisetschlager G, Bruckner T, Scheidhauer K, Schwaiger M, Vogelsang H. Radio-guided surgery <strong>for</strong> persistent differentiated papillary thyroid <strong>cancer</strong>: case presentations and review of the literature. Langenbecks Arch.Surg. 2006;391:178-86. 189. Travagli JP, Cailleux AF, Ricard M, Baudin E, Caillou B, Parmentier C et al. Combination of radioiodine (131I) and probe-guided surgery <strong>for</strong> persistent or recurrent thyroid carcinoma. J Clin Endocrinol.Metab 1998;83:2675-80. 190. Grant CS, Grant. Medullary thyroid carcinoma and associated multiple endocrine neoplasia type 2. In: Hay ID, Wass JA. Clinical endocrine oncology, Second Edition ed. Massachusetts: Blackwell Publishing, 2008:515-22. 191. Gimm O, Ukkat J, Dralle H. Determinative factors of biochemical cure <strong>af</strong>ter primary and reoperative surgery <strong>for</strong> sporadic medullary thyroid carcinoma. World J.Surg. 1998;22:562-7. 192. Kebebew E, Kikuchi S, Duh QY, Clark OH. Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid <strong>cancer</strong>. Arch.Surg. 2000;135:895-901. 193. Moley JF, Dilley WG, Debenedetti MK. Improved results of cervical reoperation <strong>for</strong> medullary thyroid carcinoma. Ann.Surg. 1997;225:734-40. 194. Moley JF, Dilley WG, Debenedetti MK. Improved results of cervical reoperation <strong>for</strong> medullary thyroid carcinoma. Ann.Surg. 1997;225:734-40. 195. Gimm O, Dralle H. Reoperation in metastasizing medullary thyroid carcinoma: is a tumor stageoriented approach justified? Surgery 1997;122:1124-30. 196. Sherman SI, Wirth LJ, Droz JP, Hofmann M, Bastholt L, Martins RG et al. Motesanib diphosphate in progressive differentiated thyroid <strong>cancer</strong>. N.Engl.J.Med. 2008;359:31-42. 197. Andersen, P. H., Kroustrup, J. P., Feldt-Rasmussen, U. F., Hangaard, J., and Brixen, K. Multipel endokrin neoplasi. Andersen, P. H., Kroustrup, J. P., Feldt-Rasmussen, U. F., Hangaard, J., and Brixen, K. 1-12. 2002. København, Læge<strong>for</strong>eningens Forlag. Klaringsrapport. Ref Type: Report 198. Eng C, Smith DP, Mulligan LM, Nagai MA, Healey CS, Ponder MA et al. Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. Hum.Mol.Genet. 1994;3:237-41. 199. Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC et al. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum.Mol.Genet. 1993;2:851-6. 200. Hofstra RM, Landsvater RM, Ceccherini I, Stulp RP, Stelwagen T, Luo Y et al. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 1994;367:375-6. 64
Thyreoidea<strong>cancer</strong> – <strong>udkast</strong> <strong>Kliniske</strong> <strong>retningslinier</strong> – revision – juni <strong>2009</strong> 201. Lips CJ, Landsvater RM, Hoppener JW, Geerdink RA, Blijham G, van VJ et al. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A [see comments]. N.Engl.J.Med. 1994;331:828-35. 202. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C et al. Guidelines <strong>for</strong> diagnosis and therapy of MEN type 1 and type 2. J.Clin.Endocrinol.Metab 2001;86:5658-71. 65